Targeting autophagy and plasminogen activator inhibitor-1 increases survival and remodels the tumor microenvironment in glioblastoma. [PDF]
Shifman SG +8 more
europepmc +1 more source
Hepatic AhR Activation by TCDD Induces Obesity and Steatosis via Hepatic Plasminogen Activator Inhibitor-1 (PAI-1). [PDF]
Oh SJ +5 more
europepmc +1 more source
Sustained Expression of Plasminogen Activator Inhibitor-1 in Patients Recovered from COVID-19 Disease. [PDF]
Mayer O +7 more
europepmc +1 more source
Aging, Plasminogen Activator Inhibitor 1, Brain Cell Senescence, and Alzheimer's Disease. [PDF]
Jiang CS +7 more
europepmc +1 more source
Role of plasminogen activator inhibitor-1 (PAI-1) in age-related cardiovascular pathophysiology. [PDF]
Khoddam A, Vaughan D, Wilsbacher L.
europepmc +1 more source
Plasminogen activator inhibitor-1 (PAI-1) [PDF]
openaire +1 more source
The Antifibrotic Effects of Plasminogen Activator Inhibitor-1 Antagonists are Observed in Rats with Epidural Fibrosis. [PDF]
Bektasoglu PK +4 more
europepmc +1 more source
Plasminogen activator inhibitor 1 is a novel predictor in human serum/follicular fluid for diminished ovarian reserve. [PDF]
Li X, Chen X, Guo H.
europepmc +1 more source
High-throughput amino acid-level characterization of the interactions of plasminogen activator inhibitor-1 with variably divergent proteases. [PDF]
Haynes LM +4 more
europepmc +1 more source
Serum Levels of Plasminogen Activator Inhibitor-1 in Patients with Parkinson's Disease. [PDF]
Tanrikulu AM, Ozdilek B, Agirbasli M.
europepmc +1 more source

